Mark Calmiano

636 total citations
5 papers, 120 citations indexed

About

Mark Calmiano is a scholar working on Molecular Biology, Computational Theory and Mathematics and Infectious Diseases. According to data from OpenAlex, Mark Calmiano has authored 5 papers receiving a total of 120 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Computational Theory and Mathematics and 1 paper in Infectious Diseases. Recurrent topics in Mark Calmiano's work include Computational Drug Discovery Methods (2 papers), Cancer therapeutics and mechanisms (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). Mark Calmiano is often cited by papers focused on Computational Drug Discovery Methods (2 papers), Cancer therapeutics and mechanisms (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). Mark Calmiano collaborates with scholars based in United Kingdom, Belgium and Switzerland. Mark Calmiano's co-authors include Christoph Meier, Mark Batchelor, Anne Foley, Richard J. Franklin, John Porter, Fabien Lecomte, Alison Maloney, Simon Lumb, William R. Pitt and Richard D. Taylor and has published in prestigious journals such as Nature, Biophysical Journal and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Mark Calmiano

5 papers receiving 116 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Calmiano United Kingdom	5	67	45	29	29	16	5	120
C. Hamlett United Kingdom	4	123 1.8×	67 1.5×	28 1.0×	24 0.8×	15 0.9×	5	188
Ruhi Kamran United States	9	69 1.0×	37 0.8×	30 1.0×	21 0.7×	49 3.1×	11	162
R. Dunsdon United Kingdom	6	70 1.0×	62 1.4×	10 0.3×	37 1.3×	27 1.7×	10	145
Jay B. Fell United States	7	132 2.0×	162 3.6×	10 0.3×	18 0.6×	15 0.9×	13	276
Pavan Vaddady United States	7	86 1.3×	92 2.0×	22 0.8×	17 0.6×	37 2.3×	24	264
Karen A. Evans United States	9	77 1.1×	201 4.5×	22 0.8×	25 0.9×	34 2.1×	16	301
Shuqun Lin United States	8	76 1.1×	95 2.1×	26 0.9×	4 0.1×	25 1.6×	9	195
Javier de Vicente United States	6	46 0.7×	36 0.8×	20 0.7×	9 0.3×	36 2.3×	6	126
Thomas E. Mabry United States	9	69 1.0×	40 0.9×	35 1.2×	20 0.7×	19 1.2×	13	185
Shon K. Booker United States	3	68 1.0×	89 2.0×	9 0.3×	25 0.9×	9 0.6×	3	133

Countries citing papers authored by Mark Calmiano

Since Specialization

Citations

This map shows the geographic impact of Mark Calmiano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Calmiano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Calmiano more than expected).

Fields of papers citing papers by Mark Calmiano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Calmiano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Calmiano. The network helps show where Mark Calmiano may publish in the future.

Co-authorship network of co-authors of Mark Calmiano

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Calmiano. A scholar is included among the top collaborators of Mark Calmiano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Calmiano. Mark Calmiano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Delft, F. von, Mark Calmiano, John D. Chodera, et al.. (2021). A white-knuckle ride of open COVID drug discovery. Nature. 594(7863). 330–332. 16 indexed citations

2.

Carrington, Bruce, William K. Myers, P.S. Horanyi, Mark Calmiano, & Alastair D. G. Lawson. (2017). Natural Conformational Sampling of Human TNFα Visualized by Double Electron-Electron Resonance. Biophysical Journal. 113(2). 371–380. 11 indexed citations

3.

Pitt, William R., et al.. (2013). Structure-Based Virtual Screening for Novel Ligands. Methods in molecular biology. 1008. 501–519. 15 indexed citations

4.

Porter, John, Simon Lumb, Richard J. Franklin, et al.. (2009). Discovery of 4-azaindoles as novel inhibitors of c-Met kinase. Bioorganic & Medicinal Chemistry Letters. 19(10). 2780–2784. 33 indexed citations

5.

Porter, John, Simon Lumb, Fabien Lecomte, et al.. (2008). Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase. Bioorganic & Medicinal Chemistry Letters. 19(2). 397–400. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact